Clinical Trial Update: Phase II Study Evaluating Safety and Efficacy of Tislelizumab for Elderly Patients Unfit for Chemotherapy, With Advanced Esophageal Squamous-cell Carcinoma [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating safety and efficacy of tislelizumab in elderly patients with advanced esophageal squamous cell carcinoma who are unfit for ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Tislelizumab (tislelizumab)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Esophageal Squamous Cell Carcinoma (ESCC) | Phase 2 | Status: RECRUITING